Topic: Cambridge–AstraZeneca

Grant: 2 grants

Grant · Toxicology

AstraZeneca Non-Clinical PhD Studentship in Development of an Integrated Pre-Clinical Pipeline for Safety Assessment of Small Molecule and Peptide-Based Radioconjugates

University of Cambridge

Closes Oct 30

Develop a preclinical safety-assessment framework for small-molecule and peptide radioconjugates. The Cambridge–AstraZeneca project combines in-vivo PET imaging with multimodal tissue analysis to study distribution and toxicity of targeted radionuclide therapies. Four years of doctoral funding support work across academic and industrial research environments.

Grant · Nanomedicine

AZ funded Non-clinical PhD Studentship (Fixed Term) in selective nanoparticle targeting of senescent alveolar epithelium using an alveolar organoid model

University of Cambridge

Closes Dec 8

Develop nanoparticle delivery of senescence-modulating therapies to lung epithelial cells in a Cambridge–AstraZeneca doctoral project. Research uses human alveolar organoids, engineered carriers and automated screening to evaluate drug selection, delivery and functional responses relevant to pulmonary fibrosis. The four-year studentship begins in October 2027.